BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27383834)

  • 1. Positive Predictive Value of the WHO Clinical and Immunologic Criteria to Predict Viral Load Failure among Adults on First, or Second-Line Antiretroviral Therapy in Kenya.
    Waruru A; Muttai H; Ng'ang'a L; Ackers M; Kim A; Miruka F; Erick O; Okonji J; Ayuaya T; Schwarcz S
    PLoS One; 2016; 11(7):e0158881. PubMed ID: 27383834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adoption of routine virologic testing and predictors of virologic failure among HIV-infected children on antiretroviral treatment in western Kenya.
    Kadima J; Patterson E; Mburu M; Blat C; Nyanduko M; Bukusi EA; Cohen C; Oyaro P; Abuogi L
    PLoS One; 2018; 13(11):e0200242. PubMed ID: 30412576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Misdiagnosis of HIV treatment failure based on clinical and immunological criteria in Eastern and Central Kenya.
    Joram SL; Paul G; Moses K; Stanley B; Isaac M; Allan G; Tom M; Lilian K; Mildred M
    BMC Infect Dis; 2017 Jun; 17(1):383. PubMed ID: 28577527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating patients for second-line antiretroviral therapy in India: the role of targeted viral load testing.
    Rewari BB; Bachani D; Rajasekaran S; Deshpande A; Chan PL; Srikantiah P
    J Acquir Immune Defic Syndr; 2010 Dec; 55(5):610-4. PubMed ID: 20890211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment failure and drug resistance in HIV-positive patients on tenofovir-based first-line antiretroviral therapy in western Kenya.
    Brooks K; Diero L; DeLong A; Balamane M; Reitsma M; Kemboi E; Orido M; Emonyi W; Coetzer M; Hogan J; Kantor R
    J Int AIDS Soc; 2016; 19(1):20798. PubMed ID: 27231099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings.
    Chang LW; Harris J; Humphreys E
    Cochrane Database Syst Rev; 2010 Apr; (4):CD008494. PubMed ID: 20393969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of WHO immunologic criteria for treatment failure: implications for detection of virologic failure, evolution of drug resistance and choice of second-line therapy in India.
    Vallabhaneni S; Chandy S; Heylen E; Ekstrand ML
    J Int AIDS Soc; 2013 Jun; 16(1):18449. PubMed ID: 23735817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic criteria are poor predictors of virologic outcome: implications for HIV treatment monitoring in resource-limited settings.
    Rawizza HE; Chaplin B; Meloni ST; Eisen G; Rao T; Sankalé JL; Dieng-Sarr A; Agbaji O; Onwujekwe DI; Gashau W; Nkado R; Ekong E; Okonkwo P; Murphy RL; Kanki PJ;
    Clin Infect Dis; 2011 Dec; 53(12):1283-90. PubMed ID: 22080121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of an algorithm for determination of the likelihood of virological failure in HIV-positive adults receiving antiretroviral therapy in decentralized care.
    Reepalu A; Balcha TT; Skogmar S; Isberg PE; Medstrand P; Björkman P
    Glob Health Action; 2017; 10(1):1371961. PubMed ID: 28914169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanded access to viral load testing and use of second line regimens in Haiti: time trends from 2010-2017.
    Wang Y; Barnhart S; Francois K; Robin E; Kalou M; Perrin G; Hall L; Koama JB; Marinho E; Balan JG; Honoré JG; Puttkammer N
    BMC Infect Dis; 2020 Apr; 20(1):283. PubMed ID: 32299389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should viral load thresholds be lowered?: Revisiting the WHO definition for virologic failure in patients on antiretroviral therapy in resource-limited settings.
    Labhardt ND; Bader J; Lejone TI; Ringera I; Hobbins MA; Fritz C; Ehmer J; Cerutti B; Puga D; Klimkait T
    Medicine (Baltimore); 2016 Jul; 95(28):e3985. PubMed ID: 27428189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the Viral Load Testing Criteria - an algorithm for targeted viral load testing in HIV-positive adults receiving antiretroviral therapy.
    Thorman J; Björkman P; Tesfaye F; Jeylan A; Balcha TT; Reepalu A
    Trop Med Int Health; 2019 Mar; 24(3):356-362. PubMed ID: 30624826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting treatment failure in adults and children on antiretroviral therapy: a systematic review of the performance characteristics of the 2010 WHO immunologic and clinical criteria for virologic failure.
    Rutherford GW; Anglemyer A; Easterbrook PJ; Horvath T; Vitoria M; Penazzato M; Doherty MC
    AIDS; 2014 Mar; 28 Suppl 2():S161-9. PubMed ID: 24849476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring virologic responses to antiretroviral therapy in HIV-infected adults in Kenya: evaluation of a low-cost viral load assay.
    Sivapalasingam S; Wangechi B; Marshed F; Laverty M; Essajee S; Holzman RS; Valentine F
    PLoS One; 2009 Aug; 4(8):e6828. PubMed ID: 19714253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of WHO immunological criteria in identifying virological failure among HIV-infected adults on First line antiretroviral therapy in Mwanza, North-western Tanzania.
    Gunda DW; Kidenya BR; Mshana SE; Kilonzo SB; Mpondo BC
    BMC Res Notes; 2017 Jan; 10(1):45. PubMed ID: 28095920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superior virologic and treatment outcomes when viral load is measured at 3 months compared to 6 months on antiretroviral therapy.
    Kerschberger B; Boulle AM; Kranzer K; Hilderbrand K; Schomaker M; Coetzee D; Goemaere E; Van Cutsem G
    J Int AIDS Soc; 2015; 18(1):20092. PubMed ID: 26403636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pooled HIV-1 RNA viral load testing for detection of antiretroviral treatment failure in Kenyan children.
    Chohan BH; Tapia K; Merkel M; Kariuki AC; Khasimwa B; Olago A; Gichohi R; Obimbo EM; Wamalwa DC
    J Acquir Immune Defic Syndr; 2013 Jul; 63(3):e87-93. PubMed ID: 23542638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A targeted approach for routine viral load monitoring in Malawian adults on antiretroviral therapy.
    Mungwira RG; Divala TH; Nyirenda OM; Kanjala M; Muwalo F; Mkandawire FA; Choko A; Taylor TE; Mallewa J; van Oosterhout JJ; Laufer MK; Laurens MB
    Trop Med Int Health; 2018 May; 23(5):526-532. PubMed ID: 29505108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single CD4 test with 250 cells/mm3 threshold predicts viral suppression in HIV-infected adults failing first-line therapy by clinical criteria.
    Gilks CF; Walker AS; Munderi P; Kityo C; Reid A; Katabira E; Goodall RL; Grosskurth H; Mugyenyi P; Hakim J; Gibb DM;
    PLoS One; 2013; 8(2):e57580. PubMed ID: 23437399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is There a Need for Viral Load Testing to Assess Treatment Failure in HIV-Infected Patients Who Are about to Change to Tenofovir-Based First-Line Antiretroviral Therapy? Programmatic Findings from Myanmar.
    Thiha N; Chinnakali P; Harries AD; Shwe M; Balathandan TP; Thein Than Tun S; Das M; Tin HH; Yi Y; Babin FX; Lwin TT; Clevenbergh PA
    PLoS One; 2016; 11(8):e0160616. PubMed ID: 27505228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.